PANCORD
PANCORD - Pancreatic Cancer Outcomes and Experimental Research Database
PANCORD is a clinical and research database based on REDCap, dedicated to the longitudinal follow-up of patients with pancreatic cancer, particularly pancreatic ductal adenocarcinoma (PDAC). It integrates patients’ demographic, pathological, radiological, and clinical characteristics, diagnostic findings, treatment course, and outcomes, including survival. For most patients, clinical data are linked to available biological specimens, enabling comprehensive investigation of the relationships between disease course, tumor biology, and treatment response.
The database provides a platform for the identification and validation of diagnostic, prognostic, and predictive biomarkers, the investigation of tumor biological heterogeneity, and the advancement of precision oncology. Its aim is to facilitate the translation of basic and translational research findings into clinical practice and ultimately improve care for patients with pancreatic cancer.
The database was established as part of the research project AZV NU23-08-00241, Development of Ex Vivo Cellular Models for Pancreatic Adenocarcinoma: Markers and Targets for Precision Medicine, funded by the Czech Health Council of the Ministry of Health of the Czech Republic.
PANCORD is jointly developed by the Department of Histology and Embryology, Faculty of Medicine, Masaryk University, the Center for Precision Medicine, Faculty of Medicine, Masaryk University and University Hospital Brno, and the Department of Surgery, Faculty of Medicine, Masaryk University and University Hospital Brno.
If you are interested in research cooperation, please
contact us
directly.